NAOV News

ENvue Medical Strengthens Patent Portfolio with New USPTO Notice of Allowance for Feeding Tube Combining Electromagnetic Navigation with Direct Visualization Through an Integrated Internal Camera

ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’

NanoVibronix Issues Letter to Shareholders

NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules